Purchases and Sales Made in Q4 2024 in Vaneck ETF Tr Vaneck Pharmaceu (PPH)
This table provides information about the institutional ownership of Vaneck ETF Tr Vaneck Pharmaceu (PPH) during Q4 2024. The information is specifically focused on institutions that hold shares of VANECK ETF TR VANECK PHARMACEU.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 13, 2025
Q4 2024
|
Phoenix Holdings Ltd.
Givatayim, L3 |
SELL
|
- |
-36.9K- 41.75% |
$3.17M - $3.5M
|
51.4K
$4.52M
|
|
|
Feb 14, 2025
Q4 2024
|
Cambridge Investment Research Advisors, Inc.
|
SELL
|
- |
-40.8K- 92.26% |
$3.51M - $3.87M
|
3.42K
$301K
|
|
|
Jan 27, 2025
Q4 2024
|
Bank Hapoalim Bm
|
SELL
|
- |
-43.8K- 91.36% |
$3.77M - $4.16M
|
4.14K
$364K
|
|
|
Feb 10, 2025
Q4 2024
|
Thrivent Financial For Lutherans
Minneapolis, MN |
SELL
|
- |
-81.8K- 34.84% |
$7.04M - $7.77M
|
153K
$13.5M
|
|
|
Feb 11, 2025
Q4 2024
|
Northwestern Mutual Wealth Management CO
|
SELL
|
- |
-160K- 98.96% |
$13.8M - $15.2M
|
1.68K
$148K
|